Results
17
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
17 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MBK | zł553.60 | 1.2% | 3.5% | zł23.5b | zł687.98 | PB1.5x | E29.9% | 0% | Banks | ||
MIL | zł8.68 | 1.6% | 3.8% | zł10.5b | zł10.79 | PB1.4x | E32.9% | 0% | Banks | ||
CPS | zł14.35 | -0.6% | 16.4% | zł9.2b | zł16.01 | PE13.6x | E21.2% | 0% | Media | ||
CAR | zł515.00 | 1.2% | -14.7% | zł7.3b | zł627.75 | PE10.9x | E16.7% | 0.1% | Retail | ||
APR | zł19.70 | 2.8% | -24.1% | zł2.6b | zł24.10 | PE13x | E21.3% | 0.8% | Retail | ||
ARH | zł40.90 | -0.2% | 47.7% | zł2.4b | zł39.34 | PE9x | E26.3% | 5.0% | Consumer Durables | ||
NWG | zł40.00 | 1.3% | 85.2% | zł1.8b | n/a | PE12.4x | E15.9% | 2.4% | Capital Goods | ||
MUR | zł34.90 | -1.1% | -5.4% | zł1.4b | zł48.05 | PE8.8x | E33.8% | 8.4% | Real Estate Management and Development | ||
PCR | zł67.10 | -0.4% | -30.0% | zł1.3b | zł93.32 | PE11x | E14.4% | 32.1% | Materials | ||
MBR | zł326.00 | 1.2% | -1.5% | zł1.1b | zł375.45 | PE15.8x | E23.7% | 4.0% | Commercial Services | ||
ATC | zł14.86 | 1.0% | -33.5% | zł1.0b | n/a | PE5.7x | E9.3% | 6.7% | Materials | ||
ASB | zł17.83 | 4.9% | -37.4% | zł989.6m | zł28.70 | PE7.6x | E17.2% | 11.5% | Tech | ||
SLV | zł48.70 | 3.1% | -16.8% | zł893.9m | zł62.15 | PE16.5x | E21.1% | n/a | Pharmaceuticals & Biotech | ||
APT | zł16.30 | -1.1% | 3.8% | zł473.5m | zł20.80 | PE11x | E21.0% | 3.7% | Tech | ||
MGT | zł61.20 | 0% | -34.5% | zł408.6m | zł85.90 | PE12.6x | E31.6% | 9.0% | Capital Goods | ||
VIN | zł9.22 | -1.5% | -13.0% | zł98.6m | zł22.30 | PE7.9x | E11.8% | 4.3% | Commercial Services | ||
PJP | zł15.20 | -1.3% | -3.8% | zł90.9m | zł24.00 | PE8x | E24.2% | 9.2% | Capital Goods |